• Go to navigation
  • Go to content
AstraZeneca Austria

Astrazeneca Worldwide

  • AstraZeneca websites
AstraZeneca

title

  • Willkommen
  • Wir über uns
  • News
    • Nachrichten
    • Medical News
    • Pressemitteilungen
    • Corporate Press Releases
  • Jobs & Karriere
  • Gesundheit interessiert ALLE
  • Für Fachkreise
  • Arzneimittelsicherheit
  • SiteMap
  • Kontakt

You are here

  • Willkommen
  • News
  • Nachrichten

Nachrichten aus der Welt der Medizin. Zur Verfügung gestellen von CMG (Current Medicine Group).
  • Seiten
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Weiter

Date

    • 06.09.2010
    • Rectal cancer incidence increasing in young patients   Physicians may be routinely underestimating the risk for rectal cancer in the young despite increasing incidence in this group, an analysis of over 7000 US individuals suggests.
    • 03.09.2010
    • Beta-1 adrenergic receptor polymorphism may increase LVH risk.   The Arg389 polymorphism of the beta-1 adrenergic receptor is associated with a higher risk for left ventricular hypertrophy than is the Gly389 polymorphism in non-diabetic acute myocardial infarction survivors, researchers report.
    • 03.09.2010
    • Clotting disorders common in hormone therapy-related thrombosis   Women who develop a thromboembolic event while taking oral contraceptives or hormone replacement therapy have a increased prevalence of clotting disorders, study findings indicate.
    • 03.09.2010
    • Complementary therapies ease prostate cancer patients’ anxiety   Prostate cancer patients being treated with radiotherapy are interested in and show benefit from complementary therapies, including Reiki and relaxation response therapy, report US researchers.
    • 03.09.2010
    • DANPACE: No AAIR pacemakers for sick sinus syndrome patients   Sick sinus syndrome patients should not receive rate-adaptive single chamber atrial pacing because of a raised risk for reoperation and atrial fibrillation when compared with rate-adaptive dual chamber pacing, conclude DANPACE investigators.
  • Seiten
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Weiter

Sie sind nicht angemeldet.



  • Passwort vergessen

Service

  • Druckversion
  • Website zu Favoriten hinzufügen

Legal notices

  • Rechtliche Hinweise
  • Impressum
  • AGB
  • Hinweise für externe Dienstleister
  • © AstraZeneca 2010